Mobix Labs Expands Role in F-22 Component Supply
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 02 2026
0mins
Should l Buy MOBX?
Mobix Labs announced a significant expansion of its role supplying mission-critical components for the F-22 Raptor fighter jet program. The Company has secured new and increased orders from two F-22 subcontractors, including a newly established customer relationship and expanded business with a long-standing partner. These orders represent approximately a five-fold increase over Mobix Labs' prior activity supporting the F-22 program.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MOBX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MOBX
About MOBX
Mobix Labs, Inc. designs, develops and sells components and systems for advanced wireless and wired connectivity, radio frequency (RF), switching and electromagnetic interference (EMI) filtering technologies. The Company's solutions are used in the consumer commercial, industrial, automotive, medical, aerospace, defense and other markets. The Company's wireless systems solutions include products for advanced RF and millimeter wave (mmWave) 5G communications, mmWave imaging, software defined radio and custom RF integrated circuits (ICs) targeting the commercial, industrial, and defense and aerospace sectors. Its interconnect products, including EMI filter inserts and filtered and non-filtered connectors, are designed for and are used in aerospace, military, defense and medical applications. Its True Xero active optical cables (AOCs) are designed to deliver fiber optic connectivity for a range of applications, including 5G infrastructure, autonomous vehicles and remote medical systems.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Mobix Labs Secures $3.2M Order for TSA Technology
- Significant Order: Mobix Labs has recently secured a $3.2 million order for TSA security scanner technology used at major U.S. airports, indicating the company's ongoing growth in the security technology sector.
- Total Program Activity: This order brings Mobix Labs' total program activity to over $6 million, reflecting strong demand and market recognition for the company's airport security technology.
- Clear Revenue Expectations: Revenue from this order is expected to be recognized over the next three quarters, with shipments scheduled through December 31, 2026, providing stable support for the company's financial performance.
- Market Risk Advisory: While the company has issued forward-looking statements, it also cautions investors about risks and uncertainties, noting that actual results may differ materially from expectations, and advises attention to relevant information in SEC filings.
See More
Mobix Labs Secures $3.2 Million Order for TSA Body Scanners
- Significant Order: Mobix Labs announced a $3.2 million order for technology used in airport body scanners deployed by the U.S. Transportation Security Administration, marking a strategic expansion in the security technology sector.
- Total Program Value: This order brings total program activity to over $6 million, with revenue expected to be recognized over the next three quarters, indicating strong performance amid growing market demand.
- Clear Shipment Schedule: Mobix Labs plans to complete all shipments by the end of 2026, ensuring a stable revenue stream and laying a solid foundation for the company's future financial performance.
- Widespread Market Application: The company's components are utilized in full-body screening systems at major U.S. airports, further solidifying its market position in aviation security technology.
See More
Mobix Labs Secures $3.2 Million TSA Scanner Contract
- Significant Contract Value: Mobix Labs announced it has secured a $3.2 million contract to supply critical technology for TSA body scanners at major U.S. airports, further solidifying its position in high-volume passenger screening operations.
- Total Program Activity Surpasses $6 Million: This new order brings Mobix Labs' total program activity to over $6 million, indicating sustained growth and expansion potential in the security screening market, which is expected to provide robust support for future financial performance.
- Clear Revenue Expectations: Mobix Labs anticipates recording revenue from this order over the next three fiscal quarters, which will enhance the company's cash flow and profitability, thereby boosting investor confidence.
- Positive Stock Reaction: In Monday's premarket trading, Mobix Labs' stock rose over 11%, reflecting the market's positive response to the new contract and recognition of the company's future growth potential.
See More
Mobix Labs Sees Five-Fold Increase in F-22 Orders
- Order Surge: Mobix Labs has reported a new customer and increased demand from an existing partner related to the F-22 Raptor program, resulting in approximately a five-fold increase in component orders, indicating strong growth potential in the defense sector.
- Production Progress: Production is currently underway to support upcoming deliveries in 2026, which not only enhances the company's production capacity but also lays the groundwork for future revenue growth.
- Market Outlook: With the significant increase in orders, Mobix Labs is solidifying its position in the defense market, likely attracting more customers and expanding market share, further driving performance improvements.
- Risk Advisory: While the company maintains an optimistic outlook on production and shipments, it is important to consider the risks and uncertainties outlined in SEC filings, as actual results may differ materially from expectations.
See More
Mobix Labs Approves 1-for-10 Reverse Stock Split
- Reverse Split Decision: Mobix Labs' board has approved a 1-for-10 reverse stock split aimed at addressing ongoing non-compliance with Nasdaq's $1 minimum bid price rule, which has been in effect since April 2025, with legal implementation set for April 6, 2026.
- Shareholder Support: The reverse split plan received shareholder approval at the annual meeting on March 23, 2026, indicating a commitment to governance and compliance that may help restore market confidence in the company's stock.
- Market Reaction: Following the announcement of the reverse split, Mobix Labs' stock price fell by 19% during pre-market trading on Thursday, reflecting market concerns regarding the company's financial health and uncertainties about future price recovery.
- Compliance Pressure: This reverse split is a direct response to Nasdaq compliance pressures, as failure to meet minimum price requirements could lead to delisting risks, further impacting investor confidence and the company's ability to raise capital.
See More
Mobix Labs Shares Plunge 25% After Reverse Stock Split Announcement
- Reverse Stock Split Plan: Mobix Labs announced a 1-for-10 reverse stock split aimed at boosting its share price to meet Nasdaq Capital Market listing requirements, set to take effect on April 6, 2026, indicating the company's urgent focus on its stock price.
- Equity Changes: The split will reduce the outstanding Class A shares from approximately 103.3 million to about 10.3 million, while Class B shares will decrease from around 2 million to roughly 200,000, significantly lowering the number of shares in circulation, which may impact liquidity.
- Market Reaction: Following the announcement, Mobix Labs shares plummeted 25% in pre-market trading, reflecting investor concerns about the company's future prospects, with the stock on track for an eighth consecutive day of decline, indicating a lack of market confidence.
- Strategic Implications: By implementing the reverse stock split, Mobix Labs aims to restore investor confidence and elevate its stock price, which, if successful, could enhance the company's market performance and financing capabilities; however, the current stock decline may exert pressure on its long-term growth.
See More
Mobix Labs Secures $3.2M Order for TSA Technology
- Significant Order: Mobix Labs has recently secured a $3.2 million order for TSA security scanner technology used at major U.S. airports, indicating the company's ongoing growth in the security technology sector.
- Total Program Activity: This order brings Mobix Labs' total program activity to over $6 million, reflecting strong demand and market recognition for the company's airport security technology.
- Clear Revenue Expectations: Revenue from this order is expected to be recognized over the next three quarters, with shipments scheduled through December 31, 2026, providing stable support for the company's financial performance.
- Market Risk Advisory: While the company has issued forward-looking statements, it also cautions investors about risks and uncertainties, noting that actual results may differ materially from expectations, and advises attention to relevant information in SEC filings.
See More
Mobix Labs Secures $3.2 Million Order for TSA Body Scanners
- Significant Order: Mobix Labs announced a $3.2 million order for technology used in airport body scanners deployed by the U.S. Transportation Security Administration, marking a strategic expansion in the security technology sector.
- Total Program Value: This order brings total program activity to over $6 million, with revenue expected to be recognized over the next three quarters, indicating strong performance amid growing market demand.
- Clear Shipment Schedule: Mobix Labs plans to complete all shipments by the end of 2026, ensuring a stable revenue stream and laying a solid foundation for the company's future financial performance.
- Widespread Market Application: The company's components are utilized in full-body screening systems at major U.S. airports, further solidifying its market position in aviation security technology.
See More
Mobix Labs Secures $3.2 Million TSA Scanner Contract
- Significant Contract Value: Mobix Labs announced it has secured a $3.2 million contract to supply critical technology for TSA body scanners at major U.S. airports, further solidifying its position in high-volume passenger screening operations.
- Total Program Activity Surpasses $6 Million: This new order brings Mobix Labs' total program activity to over $6 million, indicating sustained growth and expansion potential in the security screening market, which is expected to provide robust support for future financial performance.
- Clear Revenue Expectations: Mobix Labs anticipates recording revenue from this order over the next three fiscal quarters, which will enhance the company's cash flow and profitability, thereby boosting investor confidence.
- Positive Stock Reaction: In Monday's premarket trading, Mobix Labs' stock rose over 11%, reflecting the market's positive response to the new contract and recognition of the company's future growth potential.
See More
Mobix Labs Sees Five-Fold Increase in F-22 Orders
- Order Surge: Mobix Labs has reported a new customer and increased demand from an existing partner related to the F-22 Raptor program, resulting in approximately a five-fold increase in component orders, indicating strong growth potential in the defense sector.
- Production Progress: Production is currently underway to support upcoming deliveries in 2026, which not only enhances the company's production capacity but also lays the groundwork for future revenue growth.
- Market Outlook: With the significant increase in orders, Mobix Labs is solidifying its position in the defense market, likely attracting more customers and expanding market share, further driving performance improvements.
- Risk Advisory: While the company maintains an optimistic outlook on production and shipments, it is important to consider the risks and uncertainties outlined in SEC filings, as actual results may differ materially from expectations.
See More
Mobix Labs Approves 1-for-10 Reverse Stock Split
- Reverse Split Decision: Mobix Labs' board has approved a 1-for-10 reverse stock split aimed at addressing ongoing non-compliance with Nasdaq's $1 minimum bid price rule, which has been in effect since April 2025, with legal implementation set for April 6, 2026.
- Shareholder Support: The reverse split plan received shareholder approval at the annual meeting on March 23, 2026, indicating a commitment to governance and compliance that may help restore market confidence in the company's stock.
- Market Reaction: Following the announcement of the reverse split, Mobix Labs' stock price fell by 19% during pre-market trading on Thursday, reflecting market concerns regarding the company's financial health and uncertainties about future price recovery.
- Compliance Pressure: This reverse split is a direct response to Nasdaq compliance pressures, as failure to meet minimum price requirements could lead to delisting risks, further impacting investor confidence and the company's ability to raise capital.
See More
Mobix Labs Shares Plunge 25% After Reverse Stock Split Announcement
- Reverse Stock Split Plan: Mobix Labs announced a 1-for-10 reverse stock split aimed at boosting its share price to meet Nasdaq Capital Market listing requirements, set to take effect on April 6, 2026, indicating the company's urgent focus on its stock price.
- Equity Changes: The split will reduce the outstanding Class A shares from approximately 103.3 million to about 10.3 million, while Class B shares will decrease from around 2 million to roughly 200,000, significantly lowering the number of shares in circulation, which may impact liquidity.
- Market Reaction: Following the announcement, Mobix Labs shares plummeted 25% in pre-market trading, reflecting investor concerns about the company's future prospects, with the stock on track for an eighth consecutive day of decline, indicating a lack of market confidence.
- Strategic Implications: By implementing the reverse stock split, Mobix Labs aims to restore investor confidence and elevate its stock price, which, if successful, could enhance the company's market performance and financing capabilities; however, the current stock decline may exert pressure on its long-term growth.
See More
